Research Reference
Epitalon
Telomerase-activating tetrapeptide — longevity (pulsed 20-day courses)
Research & educational purposes only. BioMaxFit does not sell, promote, or represent peptides in any way. We are strictly educational and recommend working with your doctor on anything health-related. The information below comes from published research and documents what has been studied, not what should be done. Many of these compounds are investigational and not approved by the FDA; possession or use outside an authorized clinical trial may be illegal in your jurisdiction. This is not medical advice.
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on epithalamin, a peptide extract from the pineal gland. Developed by Russian gerontologist Professor Vladimir Khavinson, it is primarily researched for telomerase activation and longevity.
Western clinical trials are absent. Most studies come from a single Russian research group with limited independent replication.
Standard protocol: 2 mg subcutaneous daily (PM) for 20 consecutive days = 40 mg total per course, repeated 3 times per year.
Side Effects & Safety
- Injection site reactions — mild redness, minor irritation (standard for SC peptides)
- Drowsiness — some users report increased sleepiness with evening dosing (likely melatonin-related)
- Vivid dreams — frequently reported, consistent with enhanced melatonin
- Mild headache — occasional, typically transient
- Short course duration limits cumulative exposure
- Telomerase activation concern — theoretical cancer risk, though no evidence in available studies
- Cancer history — community protocols and researchers frequently note that individuals with active cancer or cancer history are typically excluded from documented protocols; no safety data exists for this population
No significant adverse events reported in Russian clinical studies.
Research Basis
Epitalon has decades of Russian research with limited Western replication.
Telomerase activation: Khavinson et al. (2003) demonstrated that Epitalon induces telomerase activity and telomere elongation in human fetal fibroblasts, extending cell division beyond the Hayflick limit (PMID 12937682).
Pineal and melatonin effects: Epithalamin treatment restored circadian melatonin rhythm in elderly human subjects, normalizing disrupted nocturnal melatonin peaks (Korkushko et al., 2004, PMID 15452611). In non-human primates, Epitalon restored age-related disturbances in pineal and pancreatic function (Goncharova et al., 2005, PMID 15664732).
Lifespan studies: Animal studies showed epithalamin/Epitalon increased mean lifespan in fruit flies and rodent models (Khavinson, 2002, PMID 12374906).
Key limitations: Most studies come from a single research group. Limited independent Western replication. Human clinical data is sparse. In vitro telomerase activation confirmed, but in vivo human telomere effects remain unconfirmed.